FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
SME IPO Status: Listed [17-05-2023 to 19-05-2023]
Remus Pharmaceuticals was listed on the stock exchange on 29-05-2023. The IPO was subscribed 57.21x. The last GMP for Remus Pharmaceuticals IPO was ₹575, updated on May 29th 2023 08:00 AM. As per the last GMP, the expected profit/loss for the IPO was 46.79%.
The issue price of Remus Pharmaceuticals IPO (REMUS) was ₹1229, listed at a price of ₹1711.25, which is 39.24% higher than the allotment price.
The expected IPO listing price as per grey market was ₹1804, listed below GMP price and marked as negative listing for GMP.
**The GMP prices shown here are only news related to the grey market. We do not trade/deal in grey market or subject to rates (sub2), nor do we recommend trading in grey market.
GMP Date | IPO Price | GMP | Sub2 Sauda Rate | Estimated Listing Price | Last Updated |
---|---|---|---|---|---|
29-05-2023 Listing | 1229 | ₹575  | 55000 | ₹1804 (46.79%) | 29-May-2023 8:00 |
28-05-2023 | 1229 | ₹575  | 55000 | ₹1804 (46.79%) | 28-May-2023 8:00 |
27-05-2023 | 1229 | ₹575  | 55000 | ₹1804 (46.79%) | 27-May-2023 19:04 |
26-05-2023 | 1229 | ₹550  | 40000 | ₹1779 (44.75%) | 26-May-2023 18:57 |
25-05-2023 | 1229 | ₹560  | 40000 | ₹1789 (45.57%) | 25-May-2023 17:20 |
24-05-2023 Allotment | 1229 | ₹450  | 40000 | ₹1679 (36.62%) | 24-May-2023 15:56 |
23-05-2023 | 1229 | ₹390  | 10000 | ₹1619 (31.73%) | 23-May-2023 16:35 |
22-05-2023 | 1229 | ₹430  | 10000 | ₹1659 (34.99%) | 22-May-2023 17:43 |
21-05-2023 | 1229 | ₹460  | 10000 | ₹1689 (37.43%) | 21-May-2023 9:58 |
20-05-2023 | 1229 | ₹450  | 10000 | ₹1679 (36.62%) | 20-May-2023 22:40 |
19-05-2023 Close | 1229 | ₹300  | 10000 | ₹1529 (24.41%) | 19-May-2023 16:54 |
18-05-2023 | 1229 | ₹70  | 10000 | ₹1299 (5.7%) | 18-May-2023 12:40 |
17-05-2023 Open | 1229 | ₹110  | 10000 | ₹1339 (8.95%) | 17-May-2023 8:00 |
16-05-2023 | 1229 | ₹110  | 10000 | ₹1339 (8.95%) | 16-May-2023 8:00 |
15-05-2023 | 1229 | ₹110  | 10000 | ₹1339 (8.95%) | 15-May-2023 17:22 |
14-05-2023 | 1229 | ₹163  | -- | ₹1392 (13.26%) | 14-May-2023 11:29 |
13-05-2023 | 1229 | ₹163  | -- | ₹1392 (13.26%) | 13-May-2023 18:22 |
12-05-2023 | 1229 | ₹160  | -- | ₹1389 (13.02%) | 12-May-2023 16:55 |
11-05-2023 | 1229 | ₹118  | -- | ₹1347 (9.6%) | 11-May-2023 16:33 |
10-05-2023 | 1229 | ₹0  | -- | ₹1229 (1%) | 10-May-2023 15:18 |
We can help you to open your demat account
Want to start your investment journey, join India’s Pioneer Discount Broker – ZERODHA – Free Delivery Trade, Maximum Rs 20 for F&O and Intraday, Free Direct Mutual Fund investment.Open Zerodha Account
InvestorGain is an affiliate of Chittorgarh.com. Check the live GMP status of all upcoming and closed IPOs (issue closed but not yet listed) on the IPO GMP Dashboard. We at InvestorGain.com regularly update IPO GMP performance. You can track and compare IPO GMP and its listing price.
The grey market premium (GMP) is the price at which an IPO is traded in an unofficial/unregulated grey market prior to its listing. The GMP reflects how a particular company’s IPO issue might react on the day of listing. A positive GMP premium signals that the IPO is likely to be at profit while a negative GMP indicates that the IPO is likely to be at a discount.
It should be noted that IPO GMP is subject to extreme volatility, so an investment decision based solely on Remus Pharmaceuticals SME IPO GMP will prove risky. Therefore, before to investing, consider all factors and make the right investment decision whether to invest in Remus Pharmaceuticals SME IPO or not.
Latest and updated information on Remus Pharmaceuticals SME IPO. Dates will be updated as they are announced.
SME IPO Activity | Date |
---|---|
SME IPO Open Date | 17-05-2023 |
SME IPO Close Date | 19-05-2023 |
Basis of Allotment Finalisation Date* |
24-05-2023 |
Refunds Initiation* | 25-05-2023 |
Credit of Shares to Demat Account* |
26-05-2023 |
SME IPO Listing Date* | 29-05-2023 |
* - Tentative Dates
Our experts can help you prepare for SME IPO
Are you an SME company looking for an IPO to raise funds and get listed in the stock market? We can help. Contact us today... SME IPO Enquiry Form
DISCLAIMER: None of the financial information published herein should be construed as an offer to buy or sell securities or as advice in any way. All information published herein is for educational and informational purposes only and should not be relied upon as a basis for investment decisions under any circumstances. Readers must consult a qualified financial advisor before making any actual investment decisions based on the information published herein. Any reader who makes decisions based on the information published herein does so solely at his or her own risk. Investors should be aware that any investment in equity markets is subject to unpredictable market-related risks. The author does not intend to invest in this offering.
Last Updated on May 29th 2023 08:00 AM
The Current GMP of Remus Pharmaceuticals SME IPO is ₹575 . The Remus Pharmaceuticals SME IPO GMP (Grey Market Premium) is the rate of premium, on which, the SME IPO is trading in the grey market or over-the-counter (OTC) market or off-exchange trading between two persons. The GMP price last updated on May 29th 2023 09:00 AM.
The estimated listing price for Remus Pharmaceuticals SME IPO is ₹1804 which is approx 46.79% gain. The latest GMP of Remus Pharmaceuticals SME IPO is ₹575. The GMP price last updated on May 29th 2023 09:00 AM.